Time-dependent affective disturbances in abstinent patients with methylphenidate use disorder

Abstract

Abstract Background Methylphenidate (MPH), also called Ritalin, is used to treat attention-deficit hyperactivity disorder (ADHD) patients. With occasional reports of subjects suffering from Methylphenidate use disorder (MPHUD), few studies analyzed the neuropsychological changes in this population. Purpose This study aims to evaluate the clinical outcomes of individuals with MPHUD. Methods We retrospectively analyzed 61 MPH patients (aged 16–27 years) admitted to the Beijing Gaoxin Hospital drug rehabilitation program from Jan 2017 to Mar 2019. The drug use history and drug abuse motivation scale were collected at admission. Clinicians rated the Hamilton Depression Rating Scale, Hamilton Anxiety Rating Scale, and DSM-5 Stimulant use disorder criteria each week during the 4 weeks rehabilitation program. Correlation analyses were conducted between drug use history and affective disturbances. Results The results showed that the adolescent period is the peak for MPH exposure, and 1/3 of patients got their first exposure to MPH from their parents. MPH abstinence accompanies severe anxiety and depression symptoms, significantly alleviating after four weeks of treatment. Conclusions MPHUD is associated with substantial affective disturbances, which warrants a more considerable sample investigation.

Keywords

• Methylphenidate
• Ritalin
• Addiction
• Depression
• Anxiety
• Adolescents